Prognostic value of dysnatremia for survival in neuroendocrine neoplasm patients

MLA

Julie Refardt, et al. “Prognostic Value of Dysnatremia for Survival in Neuroendocrine Neoplasm Patients.” European Journal of Endocrinology, vol. 187, no. 1, July 2022, pp. 209–17. EBSCOhost, https://doi.org/10.1530/EJE-22-0023.

APA

Julie Refardt, Tessa Brabander, Noémie S Minczeles, Richard A Feelders, Wouter W de Herder, & Johannes Hofland. (2022). Prognostic value of dysnatremia for survival in neuroendocrine neoplasm patients. European Journal of Endocrinology, 187(1), 209–217. https://doi.org/10.1530/EJE-22-0023

Chicago

Julie Refardt, Tessa Brabander, Noémie S Minczeles, Richard A Feelders, Wouter W de Herder, and Johannes Hofland. 2022. “Prognostic Value of Dysnatremia for Survival in Neuroendocrine Neoplasm Patients.” European Journal of Endocrinology 187 (1): 209–17. doi:10.1530/EJE-22-0023.